The NBOME's clinical-skills transition concerns how osteopathic medical students demonstrate competencies for COMLEX-USA Level 3 eligibility, beginning with the Class of 2029. C3DO and Comprehensive Competency Verification are alternative institutional pathways. They are not two question banks, and the transition does not create one national clinical examination date for every student.
This guide uses NBOME information checked on 6 September 2026. A student's college of osteopathic medicine remains the source for its chosen pathway, local arrangements and the requirements applying to the individual cohort.
The two routes in plain language
C3DO means Core Competency Capstone for DOs. The NBOME's C3DO information describes an assessment of fundamental osteopathic clinical skills delivered through participating colleges. It concerns demonstrated performance, not simply completion of an online revision resource.
Comprehensive Competency Verification, or CCV, is the alternative route through which a college documents and certifies the student's achievement of the required competencies. It should not be reduced to a learner ticking a box to confirm attendance.
The NBOME's June 2026 announcement explains the next phase of implementation. The practical question for a student is therefore not "Which exam can I buy?" but "Which route is my college using, and what will I need to demonstrate?"
Why 2027 and 2029 both appear
The NBOME FAQs, checked on 6 September 2026, state that the pilot period continues through 15 October 2027 and that the two options initially become available in November 2027 for the Class of 2029. Those dates describe implementation, not a common appointment for every candidate.
| Date or cohort | What it refers to | What not to infer |
|---|---|---|
| Through 15 October 2027 | Published end of the C3DO pilot period | Every student must attend on the final pilot day |
| November 2027 | Initial availability of the two assessment options | A single national sitting has been announced |
| Class of 2029 | The cohort for the new clinical-skills eligibility requirement | Any person taking another COMLEX examination in 2029 has an identical local process |
The distinction between calendar year and graduating class is particularly important for learners on a non-standard timeline. An individual who takes leave or changes progression should ask how the requirement applies to their circumstances rather than guessing from the expected graduation year alone.
The Level 3 format change is a separate development
The COMLEX-USA Bulletin of Information also describes Level 3 changing to a one-day examination from January 2027. That is a different change from the Class of 2029 clinical-skills verification requirement.
One concerns the format of the computer-based examination. The other concerns demonstrating clinical competencies as part of eligibility. Combining them into a single headline such as "C3DO replaces Level 3 in 2027" would be wrong.
The same bulletin distinguishes the recording of successful C3DO completion on the COMLEX-USA transcript from CCV's role in satisfying eligibility. Students should use that official description rather than assume that the two pathways generate identical documents.
Questions to resolve with the college
Ask which pathway will be used, when the relevant assessment or verification occurs and how expectations will be communicated. Establish what happens if further development is required and which records the student should retain.
Also clarify the practical setting. A campus-based assessment, an existing clinical-skills programme used for verification and a commercial simulation subscription are different arrangements. Similar words such as "clinical assessment" do not make their outcomes interchangeable.
Keep a written record of the college's guidance. An informal report from a student at another institution may describe a different implementation. That does not make it false, but it may make it irrelevant to the current student's next step.
Build a preparation plan around observable skills
Begin with the institution's requirements and feedback from supervised encounters. Separate interviewing, physical assessment, osteopathic skills, clinical reasoning and communication so that a weakness in one area is not hidden by strength in another.
An original planning example involves a learner who collects a detailed history but cannot explain which information supports the leading possibilities. More generic history-taking practice may add volume without resolving the difficulty. A focused case discussion asking for evidence, alternatives and uncertainty is a better test of that particular gap.
Another learner explains the reasoning clearly but needs observed practical work. A text or voice conversation cannot establish the physical skill. Arrange the appropriate supervised practice rather than interpreting a strong online performance as evidence that no further assessment is needed.
These examples illustrate learning choices. They are not official C3DO stations or a reconstruction of protected examination content.
What online simulation can contribute
As of September 2026, its simulation library includes a C3DO-oriented practice track within eighteen examination-specific tracks. Supported features include voice and text interaction, coached and uninterrupted modes, transcript-linked feedback and Tutor-led follow-up.
Those features can help rehearse interviewing, spoken reasoning and explanations. They do not award the NBOME credential, perform CCV, replace a college's assessment or demonstrate hands-on osteopathic competence.
A useful session begins with a narrow goal, such as justifying a differential from the information gathered. After the encounter, inspect the transcript and identify where the reasoning was expressed or left unstated. Practise again with a changed case rather than memorising a response to one familiar patient.
One complete iatroX simulation is free as of September 2026. Further simulation access is included within the shared paid learning subscription, not a separate qualification fee. Neither free access nor a subscription changes the college's assessment requirements.
Keep costs and evidence in the correct category
The NBOME's published FAQs distinguish pilot arrangements from the later institutional fee structure. Do not assume that a funded pilot means every future assessment will carry no cost, or that a fee billed to a college is necessarily the amount an individual student will pay.
A commercial preparation subscription is another category again. It purchases access to learning tools, not an examination place or a verification decision. Before spending, identify the gap that the resource would address and what the college already provides.
The most useful evidence of progress is specific: an observed improvement in the skill being practised, feedback on an unfamiliar case and a plan for remaining weaknesses. A platform score or completion badge should not be represented as satisfying a national competency requirement.
Frequently asked questions
Is C3DO compulsory for every student in the Class of 2029?
The NBOME describes C3DO and CCV as alternative routes for the relevant clinical-skills eligibility requirement. The college's implementation determines the applicable route and process.
Is November 2027 a single national C3DO examination sitting?
No, it is the published initial availability point for the options. Individual assessment arrangements are not established by that date alone.
Can an iatroX simulation complete CCV or award the C3DO credential?
No, iatroX provides learning practice rather than the institutional verification or NBOME assessment outcome. Use it alongside the college's requirements and appropriate supervised training.
<!-- Editorial note, 6 September 2026: The citation-audit article is a protocol with authored calibration examples, not a completed comparative platform evaluation. The scribed-notes article is an audit template, not a review of patient records or measured product errors. No independent clinical, specialist pharmacy or cross-jurisdiction review was completed; the clinical examples and renal calculation require the publisher's clinical review before publication. Product descriptions use public documentation and the supplied September 2026 iatroX information, not authenticated end-to-end product testing. Comprehensive mapping of commercial content to the new MFDS or CGM syllabus was not independently audited. Live examination appointments and individual eligibility were not checked. No missing existing-page slugs were guessed, and no statistical definitions or evaluation results were invented. -->